| Dr Kenneth W Brawner, OD | |
|
900 Conference Dr, Suite 15-b, Goodlettsville, TN 37072-1909 | |
| (615) 859-1912 | |
| (615) 859-1965 |
| Full Name | Dr Kenneth W Brawner |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 900 Conference Dr, Goodlettsville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477545341 | NPI | - | NPPES |
| 3594517 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODT690 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth W Brawner, OD 900 Conference Dr, Suite 15-b, Goodlettsville, TN 37072-1909 Ph: (615) 859-1912 | Dr Kenneth W Brawner, OD 900 Conference Dr, Suite 15-b, Goodlettsville, TN 37072-1909 Ph: (615) 859-1912 |
News Archive
Supporters of wider mental health care see the current debate as an opportunity to reverse long-time budget cuts across the country. Meanwhile in Texas, some mental health activists are seeking changes in detention policies.
Sangamo Therapeutics, Inc. and Pfizer Inc. today announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.
Are you genetically predisposed to tuberculosis? Scientists may now be able to answer this question and doctors may be able to adjust their therapeutic approach based on what they learn. That's because new research presented in the Journal of Leukocyte Biology suggests that two frequent mutations in an immune system gene called TLR1 are responsible for cellular changes that ultimately make us less likely to resist the disease.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.
› Verified 7 days ago
Dr. Theo Howard Ezell, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 525 Rivergate Pkwy, Suite # 2, Goodlettsville, TN 37072 Phone: 615-859-1928 | |
Heather Quintanilla, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 Glancy St Ste 208, Goodlettsville, TN 37072 Phone: 615-868-2877 | |
Dr. Walter L Choate, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 306 Northcreek Blvd, Suite 101, Goodlettsville, TN 37072 Phone: 615-851-7575 Fax: 615-851-8725 | |
Jennifer Scarlato Tekiele, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 520 Rivergate Pkwy, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3919 | |
Lorraine Snead, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1000 Rivergate Pkwy, Goodlettsville, TN 37072 Phone: 615-772-1555 Fax: 615-859-7801 | |
Joseph Sofranko, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 520 Rivergate Pkwy, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3917 | |
Dr. James M Judd, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 520 Rivergate Pkwy, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3919 |